查看購物車
  • English
  • Japanese
  • Korean
全球冷電漿市場：依產業、應用、制度和地區分類－預測至2031年
市場調查報告書
商品編碼
2131871

全球冷電漿市場：依產業、應用、制度和地區分類－預測至2031年

Cold Plasma Market by Application, by Regime - Global Forecast to 2031
出版日期: | 出版商: MarketsandMarkets | 英文 336 Pages | 訂單完成後即時交付

價格

全球冷電漿市場預計將從 2026 年的 21.5 億美元成長到 2031 年的 30.3 億美元，預測期內複合年成長率為 7.1%。

調查範圍
調查期 2026-2031
基準年 2025
預測期 2026-2031
計算單位 金額（10億美元）
部分 按行業、應用、制度、地區
目標區域 北美洲、歐洲、亞太地區、中東和非洲、南美洲

對高效低溫滅菌和表面改質醫療設備的需求日益成長，推動了冷電漿技術的應用。冷電漿能夠對熱敏性醫療設備進行非熱處理，同時減少對強效化學品的依賴，並將材料損傷降至最低。

對無菌醫療設備、感染控制和先進表面處理技術（尤其是在導管、植入、手術器械和其他聚合物醫療設備）日益成長的需求預計將推動市場成長。此外，不斷上漲的醫療保健成本、日益嚴格的滅菌要求以及基於等離子體的醫療技術的進步，也可能進一步促進冷電漿解決方案的應用。

冷等離子市場 - IMG1

“從行業細分來看，預計在預測期內，冷電漿市場的醫療產業細分領域將佔據最大佔有率。”

等離子解決方案在創傷治療、滅菌、消毒和外科手術等領域的日益普及，是推動醫療產業對冷電漿技術需求成長的主要動力。慢性傷口盛行率的上升、微創手術需求的成長以及對感染控制日益重視，都促進了醫院、診所和醫療設備製造廠對冷電漿系統的應用。此外，人們對非熱滅菌、抗菌治療、減少化學品使用、病患安全以及環保型醫療保健流程的日益關注，也推動了冷電漿技術的應用。常壓電漿噴流、等離子體創傷護理設備和等離子體滅菌系統的技術進步，進一步拓展了冷電漿的應用範圍，預計將使醫療保健行業在預測期內佔據最大的市場佔有率。

“按應用領域分類，表面處理和活化領域預計將在冷電漿市場中實現最高的複合年成長率。”

按應用領域分析數據，預計表面處理和活化領域在預測期內將實現最高的複合年成長率。這一成長主要歸功於冷電漿技術在聚合物和塑膠、紡織品、電子和汽車等應用領域中日益廣泛的應用，該技術能夠有效改善表面附著力、潤濕性、印刷性和黏合性能。

由於冷電漿具有非熱處理、環境友善以及減少對化學處理的依賴等優點，正日益受到各行業的青睞。此外，等離子體技術的進步、應用型系統的開發以及對高效、可定製表面處理解決方案日益成長的需求，預計將進一步加速該領域的成長。

“按運行條件分類，低壓冷電漿領域預計將在冷電漿市場中實現最高的複合年成長率。”

低壓冷電漿領域預計將實現最高的複合年成長率，這主要得益於其在高精度製造過程中日益廣泛的應用，尤其是在半導體製造、電子元件加工和特殊醫療應用領域。此領域具有在可控真空條件下運作的優勢，能夠實現精確的等離子體密度、均勻的加工效果和高度可重複的製程結果。對先進製造設施投資的增加以及等離子體製程與自動化生產線的日益融合，預計將進一步加速低壓系統的應用。

“從區域分類來看，歐洲在冷電漿市場中佔據最大佔有率。”

全球冷電漿市場分為五大區域：北美、歐洲、亞太、拉丁美洲以及中東和非洲。預計歐洲將佔據全球冷電漿市場的重要佔有率，這主要得益於冷電漿技術在醫療、聚合物和塑膠、紡織以及電子行業的日益普及，以及該地區主要市場參與者的強大影響力。

先進的製造能力、嚴格的環境法規、對永續和無化學加工工藝日益成長的需求以及對醫療保健技術投資的增加，都進一步推動了該地區市場的發展。此外，冷電漿在醫療設備滅菌、創傷護理、感染控制和工業表面處理等領域的日益普及，以及持續的技術進步和研發活動，預計將進一步推動歐洲市場的成長。

冷電漿市場的主要企業包括：Apyx Medical（美國）、Nordson Corporation（美國）、Adtec Plasma Technology（日本）、P2i Ltd.（英國）、Relyon Plasma GmbH（德國）、Henniker Plasma（英國）、Enercon Industries Corporation（美國）、AcXys Plasc Technologies Pplas） NV（比利時）、Thierry Corp.（德國）、Surfx Technologies, LLC（美國）、SOFTAL Corona & Plasma GmbH（德國）、Coating Plasma Innovation（法國）、Ferrarini & Benelli（義大利）、Neoplas GmbH（德國）、Terraplasma GmbH（德國）、MolecIN（德國）

調查範圍

本報告從行業、應用、運行模式和地區四個維度對冷電漿市場進行了分析。報告還檢驗了影響市場成長的因素，例如促進因素、限制因素、機會和挑戰，並詳細資訊了領導企業之間的競爭格局。此外，報告還基於各個細分市場的成長趨勢進行了分析，並對五大主要地區（以及這些地區內的各個國家）的市場細分收入進行了預測。

購買本報告的理由

這份報告不僅能幫助現有企業，還能幫助新參與企業和中小企業了解市場趨勢，最終幫助他們擴大市場佔有率。購買這份報告的企業可以運用以下一種或多種策略來鞏固其市場地位。

本報告深入分析了以下幾點：

  • 對關鍵促進因素（不斷擴大的益處和更廣泛的應用範圍、在創傷治療中日益廣泛的應用、在癌症和感染疾病中不斷擴大的應用、技術進步以及對非熱滅菌和表面處理日益成長的需求）、阻礙因素（高資本投資、低等離子體穿透性和工藝不均勻性）、機會（永續和減少化學品的使用以及新興國家提供的機會）和挑戰（商業化有限、對活性物質和製程條件的認知和管理水平低）的分析。
  • 產品改良與創新：全面詳細資訊全球冷電漿市場的新產品發表與預期趨勢。
  • 產品開發/創新：對全球冷電漿市場的未來趨勢、研發活動和新產品發布進行詳細分析。
  • 市場發展：提供盈利新興市場的全面信息，按行業、應用和組織結構進行細分。
  • 市場多元化：提供有關全球冷電漿市場的新產品和服務、現有產品和服務的改進、快速成長的地區、最新趨勢和投資機會的全面資訊。
  • 競爭分析：對全球冷電漿市場主要競爭對手的市場佔有率、成長計劃、產品和服務以及生產能力進行全面評估。

目錄

第1章：引言

第2章執行摘要

第3章重要考察

第4章 市場概覽

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
    • 任務
  • 未滿足的需求和未開發的領域
  • 相互關聯的市場與跨產業機遇
  • 一級/二級/三級公司的策略性舉措

第5章 產業趨勢

  • 波特五力分析
  • 宏觀經濟展望
  • 供應鏈分析
  • 價值鏈分析
  • 生態系分析
  • 價格分析
  • 貿易分析
  • 2026-2027 年主要會議和活動
  • 影響我們客戶公司業務的趨勢/變化
  • 投資和資金籌措場景
  • 案例研究分析
  • 2025年美國關稅對冷電漿市場的影響。

第6章：技術進步、人工智慧的影響、專利、創新與未來應用

  • 主要新興技術
  • 互補技術
  • 鄰近技術
  • 技術/產品藍圖
  • 專利分析
  • 未來應用
  • 人工智慧/生成式人工智慧對冷電漿市場的影響

第7章：監理情勢與永續性舉措

  • 當地法規和合規性
  • 對永續性的承諾
  • 監理政策對永續性舉措的影響

第8章：顧客趨勢與購買行為

  • 決策流程
  • 主要相關人員和採購標準
  • 實施障礙和內部挑戰
  • 各個終端用戶產業尚未滿足的需求
  • 市場盈利

第9章：冷電漿市場（依行業分類）

  • 聚合物和塑膠產業
  • 紡織業
  • 電子和半導體行業
  • 食品及農業產業
  • 醫療業
  • 化妝品產業
  • 製藥業
  • 其他

第10章：冷電漿市場（依應用領域分類）

  • 表面處理和活化
  • 塗層和薄膜沉積
  • 印刷
  • 滅菌和消毒
  • 創傷治療
  • 表面蝕刻
  • 外科應用
  • 美容皮膚科治療
  • 其他

第11章：冷電漿市場（依制度）

  • 大氣壓力冷電漿
  • 低壓冷電漿

第12章：冷電漿市場（按地區分類）

  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太地區宏觀經濟展望
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 中東和非洲宏觀經濟展望
    • 海灣合作理事會國家
    • 其他

第13章 競爭格局

  • 主要參與企業的策略/優勢，2023-2026 年
  • 2023-2025年收入分析
  • 2025年市佔率分析
  • 企業估值矩陣：主要公司，2025 年
  • 公司估值矩陣：新創企業/中小企業，2025 年
  • 企業估值和財務指標
  • 品牌/產品對比
  • 競爭格局

第14章：公司簡介

  • 主要參與企業
    • NORDSON CORPORATION
    • ADTEC PLASMA TECHNOLOGY CO., LTD.
    • JUDGES SCIENTIFIC PLC
    • PVA TEPLA AG
    • BODYCOTE
    • APYX MEDICAL CORPORATION
    • VIROMED MEDICAL AG
    • SAMCO INC.
    • MYCRONIC
    • PLASMATREAT GMBH
    • P2I LTD
    • ENERCON INDUSTRIES CORPORATION
    • TANTEC A/S
    • ACXYS TECHNOLOGIES
    • KEYLINK
  • 其他公司
    • DIENER ELECTRONIC GMBH & CO.KG
    • US MEDICAL INNOVATIONS
    • LEAFLIFE TECHNOLOGY
    • SOFTAL CORONA & PLASMA GMBH
    • FERRARINI & BENELLI SRL
    • NEOPLAS MED GMBH
    • TERRAPLASMA GMBH
    • MOLECULAR PLASMA GROUP
    • CINOGY TECHNOLOGIES GMBH
    • PLASMALEX

第15章：調查方法

第16章附錄

Product Code: MD 5001

The global cold plasma market is projected to reach USD 3.03 billion by 2031 from USD 2.15 billion in 2026, at a CAGR of 7.1 % during the forecast period.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsIndustry, Application, Regime, and Region
Regions coveredNorth America, Europe, Asia Pacific, Middle East & Africa, and South America

The growing need for effective, low-temperature sterilization and surface modification of medical devices is driving the adoption of cold plasma technology. Cold plasma enables non-thermal treatment of heat-sensitive medical devices while reducing reliance on harsh chemicals and minimizing material damage.

Increasing demand for sterile medical equipment, infection control, and advanced surface treatment, particularly for catheters, implants, surgical instruments, and other polymer-based devices, is expected to support market growth. Furthermore, rising healthcare expenditure, stringent sterilization requirements, and advancements in plasma-based medical technologies are likely to drive further adoption of cold plasma solutions.

Cold Plasma Market - IMG1

"Based on industry, the medical industry segment of the cold plasma market is expected to register the highest share during the forecast period."

The growing adoption of plasma-based solutions for wound healing, sterilization, disinfection, and surgical applications mainly drives the demand for cold plasma technology in the medical industry. The increasing prevalence of chronic wounds, rising demand for minimally invasive procedures, and growing emphasis on infection prevention are supporting the adoption of cold plasma systems across hospitals, clinics, and medical-device manufacturing facilities. Moreover, the focus on non-thermal sterilization, antimicrobial treatment, reduced chemical usage, patient safety, and environmentally friendly healthcare processes is encouraging the adoption of cold plasma technologies. Technological advancements in atmospheric-pressure plasma jets, plasma-based wound-care devices, and plasma sterilization systems are further expanding the scope of cold plasma applications, supporting the medical industry segment in registering the highest share during the forecast period.

"By application, the surface treatment & activation segment is expected to capture the highest CAGR of the cold plasma market."

Based on application, the surface treatment & activation segment is anticipated to register the highest CAGR during the forecast period. This growth can be attributed to the increasing use of cold plasma to enhance surface adhesion, wettability, printability, and bonding properties across polymer & plastics, textiles, electronics, and automotive applications.

The non-thermal, environmentally friendly nature of cold plasma, along with its ability to reduce reliance on chemical treatments, is driving its adoption across industries. Moreover, advancements in plasma technology, development of application-specific systems, and increasing demand for efficient and customizable surface treatment solutions are expected to further accelerate segment growth.

"By regime, the low-pressure cold plasma segment is expected to register the highest CAGR in the cold plasma market."

The low-pressure cold plasma segment is projected to record the highest CAGR, primarily due to its increasing use in high-precision manufacturing processes, particularly in semiconductor fabrication, electronics component processing, and specialized medical applications. The segment benefits from the ability to operate under controlled vacuum conditions, enabling precise plasma density, treatment uniformity, and repeatable process outcomes. Rising investments in advanced manufacturing facilities and the increasing integration of plasma-based processes into automated production lines are expected to further accelerate the adoption of low-pressure systems.

"Europe accounted for the largest share of the cold plasma market by region."

The global cold plasma market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe is expected to account for a significant share of the global cold plasma market, supported by the increasing adoption of cold plasma technologies across medical, polymer & plastic, textile, and electronics industries, as well as the strong presence of key market players in the region.

The regional market is further supported by advanced manufacturing capabilities, stringent environmental regulations, growing demand for sustainable and chemical-free processing, and increasing investments in healthcare technologies. Moreover, the rising adoption of cold plasma for medical device sterilization, wound care, infection control, and industrial surface treatment, along with ongoing technological advancements and R&D activities, is expected to further drive market growth in Europe.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1 (45%), Tier 2 (25%), and Tier 3 (30%)
  • By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
  • By Region: North America (35%), Europe (25%), Asia Pacific (20%), Latin America (15%), and the Middle East & Africa (5%)

The major players operating in the cold plasma market are Apyx Medical (US), Nordson Corporation (US), Adtec Plasma Technology Co. Ltd. (Japan), P2i Ltd. (UK), Relyon Plasma GmbH (Germany), Henniker Plasma (UK), Enercon Industries Corporation (US), AcXys Plasma Technologies (France), Plasmatreat GmbH (Germany), Tantec A/S (Denmark), Europlasma NV (Belgium), Thierry Corp. (Germany), Surfx Technologies, LLC (US), SOFTAL Corona & Plasma GmbH (Germany), Coating Plasma Innovation (France), Ferrarini & Benelli (Italy), Neoplas GmbH (Germany), Terraplasma GmbH (Germany), Molecular Plasma Group SA (Germany), and CINOGY Technologies GmbH (Germany).

Research Coverage

This report studies the cold plasma market by industry, application, regime, and region. The report also examines factors such as drivers, restraints, opportunities, and challenges affecting market growth and provides details on the competitive landscape among market leaders. Furthermore, the report analyzes micromarkets by their individual growth trends and forecasts revenue for market segments across five major regions (and the countries within these regions).

Reasons to Buy the Report

The report will enable established firms, as well as entrants/smaller firms, to gauge the pulse of the market, which, in turn, will help them garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.

This report provides insights on the following pointers:

  • Analysis of key drivers (increased benefits and wider application, rising use in wound healing, growing applications in cancer and infectious disease, technological advancements, and rising demand for non-thermal sterilization and surface treatment), restraints (high capital investments and limited plasma penetration and non-uniform treatment), opportunities (sustainable and chemical-reduced processing and emerging countries offering opportunities), and challenges (limited commercialization and awareness and management of reactive species and process conditions)
  • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global cold plasma market.
  • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global cold plasma market
  • Market Development: Comprehensive information on the lucrative emerging markets by industry, application, and regime.
  • Market Diversification: Exhaustive information about new products and services or product and service enhancements, growing geographies, recent developments, and investments in the global cold plasma market.
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global cold plasma market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN COLD PLASMA MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 COLD PLASMA MARKET OVERVIEW
  • 3.2 ASIA PACIFIC: COLD PLASMA MARKET, BY COUNTRY AND END USER
  • 3.3 GEOGRAPHIC SNAPSHOT OF COLD PLASMA MARKET

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Growing preference for low-temperature and chemical-reduced processing to drive cold plasma adoption
      • 4.2.1.2 Rising use of cold plasma in wound healing
      • 4.2.1.3 Emerging applications in oncology and infectious diseases
      • 4.2.1.4 Technological advancements and product innovation
      • 4.2.1.5 Rising demand for non-thermal sterilization and surface treatment for medical devices
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 High initial investments
      • 4.2.2.2 Limited plasma penetration and non-uniform treatment
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Growing focus on sustainable and chemical-reduced processing
      • 4.2.3.2 Favorable prospects in emerging economies
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Limited commercialization and awareness
      • 4.2.4.2 Management of reactive species and process conditions during cold plasma operations
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN COLD PLASMA MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF BUYERS
    • 5.1.4 BARGAINING POWER OF SUPPLIERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC OUTLOOK
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS & FORECAST
    • 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRIES
    • 5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
  • 5.3 SUPPLY CHAIN ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 PRICING ANALYSIS
    • 5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER (2023-2025)
    • 5.6.2 AVERAGE SELLING PRICE TREND, BY REGIME (2023-2025)
    • 5.6.3 AVERAGE SELLING PRICE TREND, BY REGION (2023-2025)
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT SCENARIO (HS CODE 901890)
    • 5.7.2 EXPORT SCENARIO (HS CODE 901890)
  • 5.8 KEY CONFERENCES & EVENTS, 2026-2027
  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.10 INVESTMENT & FUNDING SCENARIO
  • 5.11 CASE STUDY ANALYSIS
    • 5.11.1 CASE STUDY 1: COLD ATMOSPHERIC ARGON PLASMA FOR CHRONIC WOUND TREATMENT
    • 5.11.2 CASE STUDY 2: PLASMA SURFACE ACTIVATION OF PEEK FOR MEDICAL DEVICES
    • 5.11.3 CASE STUDY 3: PLASMA ACTIVATION FOR HIGH-QUALITY PAD PRINTING
  • 5.12 IMPACT OF 2025 US TARIFFS-COLD PLASMA MARKET
    • 5.12.1 INTRODUCTION
    • 5.12.2 KEY TARIFF RATES
    • 5.12.3 PRICE IMPACT ANALYSIS
    • 5.12.4 IMPACT ON COUNTRIES/REGIONS
      • 5.12.4.1 Canada
      • 5.12.4.2 Asia Pacific
      • 5.12.4.3 Europe

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 DIELECTRIC BARRIER DISCHARGE (DBD)
    • 6.1.2 ATMOSPHERIC PRESSURE PLASMA JET (APPJ)
    • 6.1.3 PLASMA-ACTIVATED WATER/LIQUID (PAW/PAL)
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 ULTRAVIOLET LIGHT
    • 6.2.2 HYDROGEN PEROXIDE-BASED STERILIZATION
    • 6.2.3 LASER TECHNOLOGY
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 NANOTECHNOLOGY AND ANTIMICROBIAL COATINGS
    • 6.3.2 ADVANCED SURFACE TREATMENT TECHNOLOGIES
  • 6.4 TECHNOLOGY/PRODUCT ROADMAP
    • 6.4.1 NEAR-TERM (2025-2027) INCLUDES ALL INDUSTRIES
    • 6.4.2 MID-TERM (2028-2030)
    • 6.4.3 LONG-TERM (2030+)
  • 6.5 PATENT ANALYSIS
    • 6.5.1 JURISDICTION & TOP APPLICANT ANALYSIS
  • 6.6 FUTURE APPLICATIONS
    • 6.6.1 PLASMA-ASSISTED PHARMACEUTICAL AND DRUG DELIVERY APPLICATIONS
    • 6.6.2 ADVANCED AGRICULTURAL AND PLANT-PRODUCTION APPLICATIONS
    • 6.6.3 FOOD WASTE VALORIZATION AND VALUE-ADDED FOOD PROCESSING
    • 6.6.4 ADVANCED CONTAMINANT REMEDIATION IN WATER AND WASTEWATER
    • 6.6.5 PLASMA-FUNCTIONALIZED BIOMATERIALS AND ADVANCED THERAPEUTIC MATERIALS
  • 6.7 IMPACT OF AI/GENERATIVE AI ON COLD PLASMA MARKET
    • 6.7.1 TOP USE CASES AND MARKET POTENTIAL
    • 6.7.2 BEST PRACTICES
    • 6.7.3 CASE STUDIES OF AI IMPLEMENTATION
    • 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
    • 6.7.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN COLD PLASMA MARKET

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

  • 7.1 REGIONAL REGULATIONS & COMPLIANCE
    • 7.1.1 NORTH AMERICA
    • 7.1.2 EUROPE
    • 7.1.3 ASIA PACIFIC
    • 7.1.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.5 INDUSTRY STANDARDS
      • 7.1.5.1 Medical Electrical Equipment Safety Standard - IEC 60601-1
      • 7.1.5.2 Non-thermal Plasma Wound-treatment Equipment Standard - IEC 60601-2-91:2026
      • 7.1.5.3 Quality Management System Standard For Medical Devices- ISO 13485:2016
      • 7.1.5.4 Cold Atmospheric Pressure Plasma Characterization Specification - DIN SPEC 91315:2025-07
      • 7.1.5.5 Environmental Management System Standard - ISO 14001:2026
      • 7.1.5.6 Quality Management System Standard - ISO 9001:2015
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 SUSTAINABLE SURFACE TREATMENT THROUGH ATMOSPHERIC PLASMA - PLASMATREAT GMBH
    • 7.2.2 REDUCING VOLATILE ORGANIC COMPOUND (VOCS) AND CHEMICAL USE THROUGH ATMOSPHERIC PLASMA - MYCRONIC
  • 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
    • 7.3.1 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
    • 8.1.1 DECISION-MAKING PROCESS
  • 8.2 KEY STAKEHOLDERS & BUYING CRITERIA
    • 8.2.1 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 8.5 MARKET PROFITABILITY

9 COLD PLASMA MARKET, BY INDUSTRY

  • 9.1 INTRODUCTION
  • 9.2 POLYMER & PLASTIC INDUSTRY
    • 9.2.1 GROWING ADOPTION OF ECO-FRIENDLY SURFACE MODIFICATION TECHNOLOGIES
  • 9.3 TEXTILE INDUSTRY
    • 9.3.1 COLD PLASMA TECHNOLOGY OFFERS COST-SAVING AND ECO-FRIENDLY OPTIONS FOR TEXTILE PROCESSING
  • 9.4 ELECTRONICS & SEMICONDUCTOR INDUSTRY
    • 9.4.1 GROWING SEMICONDUCTOR INDUSTRY DEMANDS SUPPORT ADOPTION OF ADVANCED PLASMA PROCESSING TECHNOLOGIES
  • 9.5 FOOD & AGRICULTURE INDUSTRY
    • 9.5.1 GROWING ADOPTION OF NON-THERMAL TECHNOLOGIES FOR FOOD PROCESSING AND AGRICULTURAL APPLICATIONS
  • 9.6 MEDICAL INDUSTRY
    • 9.6.1 GROWING CLINICAL ADOPTION OF COLD PLASMA FOR WOUND HEALING AND ANTIMICROBIAL APPLICATIONS
  • 9.7 COSMETICS INDUSTRY
    • 9.7.1 EXPANDING APPLICATION OF COLD PLASMA IN DERMATOLOGICAL AND AESTHETIC TREATMENTS
  • 9.8 PHARMACEUTICAL INDUSTRY
    • 9.8.1 EXPANDING APPLICATION OF COLD PLASMA IN PHARMACEUTICAL STERILIZATION AND DRUG DELIVERY
  • 9.9 OTHER INDUSTRIES

10 COLD PLASMA MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
  • 10.2 SURFACE TREATMENT & ACTIVATION
    • 10.2.1 INCREASING DEMAND FOR IMPROVED SURFACE ADHESION AND ACTIVATION IN POLYMER PROCESSING
  • 10.3 COATING & THIN-FILM DEPOSITION
    • 10.3.1 INCREASING APPLICATION OF COLD PLASMA FOR FUNCTIONAL AND PROTECTIVE SURFACE COATINGS
  • 10.4 PRINTING
    • 10.4.1 BETTER DYE UPTAKE & PRINTING PERFORMANCE AND REDUCED RELIANCE ON WATER/CHEMICAL PRETREATMENT DRIVES ADOPTION
  • 10.5 STERILIZATION & DECONTAMINATION
    • 10.5.1 INCREASING APPLICATION OF COLD PLASMA FOR STERILIZATION & DECONTAMINATION DRIVES MARKET
  • 10.6 WOUND HEALING
    • 10.6.1 RISING PREVALENCE OF CHRONIC WOUNDS SUPPORTS USAGE OF COLD PLASMA IN WOUND MANAGEMENT
  • 10.7 SURFACE ETCHING
    • 10.7.1 INCREASING REQUIREMENT FOR HIGH-PRECISION PLASMA ETCHING IN SEMICONDUCTOR MANUFACTURING
  • 10.8 SURGICAL APPLICATIONS
    • 10.8.1 EXPANDING APPLICATIONS OF COLD PLASMA IN SURGICAL PROCEDURES AND CANCER TREATMENT
  • 10.9 AESTHETIC SKIN PROCEDURES
    • 10.9.1 INCREASING DEMAND FOR NON-SURGICAL AESTHETIC PROCEDURES SUPPORTS COLD PLASMA APPLICATIONS
  • 10.10 OTHER APPLICATIONS

11 COLD PLASMA MARKET, BY REGIME

  • 11.1 INTRODUCTION
  • 11.2 ATMOSPHERIC COLD PLASMA
    • 11.2.1 INCREASING ADOPTION OF ATMOSPHERIC COLD PLASMA FOR SCALABLE AND EFFICIENT SURFACE TREATMENT
  • 11.3 LOW-PRESSURE COLD PLASMA
    • 11.3.1 HIGH TREATMENT EFFECTIVENESS SUPPORTS APPLICATIONS DESPITE VACUUM-SYSTEM LIMITATIONS

12 COLD PLASMA MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 12.2.2 US
      • 12.2.2.1 Strong semiconductor investment, food-safety requirements, and medical applications support market growth
    • 12.2.3 CANADA
      • 12.2.3.1 Rising cancer cases & R&D to drive market growth in Canada
  • 12.3 EUROPE
    • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 12.3.2 GERMANY
      • 12.3.2.1 Strong industrial base and demand for sustainable processing technologies propel adoption
    • 12.3.3 FRANCE
      • 12.3.3.1 Strong electronics and semiconductor investments support cold plasma market growth
    • 12.3.4 UK
      • 12.3.4.1 Investments in semiconductor and agricultural technologies support cold plasma adoption
    • 12.3.5 ITALY
      • 12.3.5.1 Aging population and healthcare investment support cold plasma market growth
    • 12.3.6 SPAIN
      • 12.3.6.1 Growing healthcare needs and cancer burden support cold plasma applications in Spain
    • 12.3.7 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 12.4.2 CHINA
      • 12.4.2.1 Strong textile, electronics, and food-processing industries support cold plasma adoption in China
    • 12.4.3 JAPAN
      • 12.4.3.1 Aging population, healthcare needs, and advanced manufacturing support cold plasma applications in Japan
    • 12.4.4 INDIA
      • 12.4.4.1 Growing R&D investment and textile exports support cold plasma adoption in India
    • 12.4.5 AUSTRALIA
      • 12.4.5.1 Growing healthcare needs and medical R&D support cold plasma adoption in Australia
    • 12.4.6 SOUTH KOREA
      • 12.4.6.1 Government support and advanced healthcare infrastructure support cold plasma adoption in South Korea
    • 12.4.7 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 12.5.2 BRAZIL
      • 12.5.2.1 Growing R&D investment and healthcare innovation support cold plasma adoption in Brazil
    • 12.5.3 MEXICO
      • 12.5.3.1 Growing healthcare needs support cold plasma adoption in Mexico
    • 12.5.4 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 12.6.2 GCC COUNTRIES
      • 12.6.2.1 Kingdom of Saudi Arabia
        • 12.6.2.1.1 Healthcare modernization and technology development drive cold plasma adoption in Saudi Arabia
      • 12.6.2.2 UAE
        • 12.6.2.2.1 Healthcare innovation and advanced technology development support cold plasma adoption in the UAE
      • 12.6.2.3 Rest of GCC Countries
    • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023-2026
    • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN COLD PLASMA MARKET
  • 13.3 REVENUE ANALYSIS, 2023-2025
  • 13.4 MARKET SHARE ANALYSIS, 2025
    • 13.4.1 GLOBAL SHARE ANALYSIS FOR COLD PLASMA MARKET (2025)
    • 13.4.2 US MARKET SHARE ANALYSIS FOR COLD PLASMA MARKET (2025)
    • 13.4.3 EUROPE MARKET SHARE ANALYSIS FOR COLD PLASMA MARKET (2025)
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 13.5.5.1 Company footprint
      • 13.5.5.2 Region footprint
      • 13.5.5.3 Industry footprint
      • 13.5.5.4 Application footprint
      • 13.5.5.5 Regime footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 13.6.5.1 Detailed list of key startups/SMEs
      • 13.6.5.2 Competitive benchmarking of key startups/SMEs
  • 13.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 13.7.1 FINANCIAL METRICS
    • 13.7.2 COMPANY VALUATION
  • 13.8 BRAND/PRODUCT COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT LAUNCHES & APPROVALS
    • 13.9.2 DEALS
    • 13.9.3 EXPANSIONS
    • 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 NORDSON CORPORATION
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Deals
        • 14.1.1.3.2 Expansions
        • 14.1.1.3.3 Other developments
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Right to win
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses & competitive threats
    • 14.1.2 ADTEC PLASMA TECHNOLOGY CO., LTD.
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Product launches
        • 14.1.2.3.2 Deals
        • 14.1.2.3.3 Expansions
        • 14.1.2.3.4 Other developments
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Right to win
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses and competitive threats
    • 14.1.3 JUDGES SCIENTIFIC PLC
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Product launches & updates
        • 14.1.3.3.2 Deals
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Right to win
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses and competitive threats
    • 14.1.4 PVA TEPLA AG
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products offered
      • 14.1.4.3 MnM view
        • 14.1.4.3.1 Right to win
        • 14.1.4.3.2 Strategic choices
        • 14.1.4.3.3 Weaknesses and competitive threats
    • 14.1.5 BODYCOTE
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Other developments
      • 14.1.5.4 MnM view
        • 14.1.5.4.1 Right to win
        • 14.1.5.4.2 Strategic choices
        • 14.1.5.4.3 Weaknesses and competitive threats
    • 14.1.6 APYX MEDICAL CORPORATION
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Product launches & approvals
        • 14.1.6.3.2 Other developments
    • 14.1.7 VIROMED MEDICAL AG
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Product approvals
        • 14.1.7.3.2 Deals
        • 14.1.7.3.3 Other developments
    • 14.1.8 SAMCO INC.
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Product launches
    • 14.1.9 MYCRONIC
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products offered
      • 14.1.9.3 Recent developments
        • 14.1.9.3.1 Deals
        • 14.1.9.3.2 Other developments
    • 14.1.10 PLASMATREAT GMBH
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products offered
      • 14.1.10.3 Recent developments
        • 14.1.10.3.1 Product launches
        • 14.1.10.3.2 Deals
        • 14.1.10.3.3 Expansions
        • 14.1.10.3.4 Other developments
    • 14.1.11 P2I LTD
      • 14.1.11.1 Business overview
      • 14.1.11.2 Products offered
      • 14.1.11.3 Recent developments
        • 14.1.11.3.1 Deals
        • 14.1.11.3.2 Other developments
    • 14.1.12 ENERCON INDUSTRIES CORPORATION
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products offered
      • 14.1.12.3 Recent developments
        • 14.1.12.3.1 Product launches
        • 14.1.12.3.2 Expansions
    • 14.1.13 TANTEC A/S
      • 14.1.13.1 Business overview
      • 14.1.13.2 Products offered
      • 14.1.13.3 Recent developments
        • 14.1.13.3.1 Product launches
        • 14.1.13.3.2 Deals
    • 14.1.14 ACXYS TECHNOLOGIES
      • 14.1.14.1 Business overview
      • 14.1.14.2 Products offered
      • 14.1.14.3 Recent developments
        • 14.1.14.3.1 Product launches
    • 14.1.15 KEYLINK
      • 14.1.15.1 Business overview
      • 14.1.15.2 Products offered
      • 14.1.15.3 Recent developments
        • 14.1.15.3.1 Other developments
  • 14.2 OTHER PLAYERS
    • 14.2.1 DIENER ELECTRONIC GMBH & CO.KG
    • 14.2.2 US MEDICAL INNOVATIONS
    • 14.2.3 LEAFLIFE TECHNOLOGY
    • 14.2.4 SOFTAL CORONA & PLASMA GMBH
    • 14.2.5 FERRARINI & BENELLI SRL
    • 14.2.6 NEOPLAS MED GMBH
    • 14.2.7 TERRAPLASMA GMBH
    • 14.2.8 MOLECULAR PLASMA GROUP
    • 14.2.9 CINOGY TECHNOLOGIES GMBH
    • 14.2.10 PLASMALEX

15 RESEARCH METHODOLOGY

  • 15.1 RESEARCH DATA
    • 15.1.1 SECONDARY DATA
      • 15.1.1.1 Key data from secondary sources
    • 15.1.2 PRIMARY DATA
      • 15.1.2.1 Key data from primary sources
      • 15.1.2.2 Key industry insights
      • 15.1.2.3 Breakdown of primary interviews
      • 15.1.2.4 Key industry insights
  • 15.2 MARKET SIZE ESTIMATION
    • 15.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
    • 15.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
    • 15.2.3 BOTTOM-UP APPROACH: SUPPLY-SIDE ANALYSIS
    • 15.2.4 TOP-DOWN APPROACH
    • 15.2.5 BASE NUMBER CALCULATION
    • 15.2.6 DEMAND-SIDE APPROACH
  • 15.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 15.4 MARKET SHARE ASSESSMENT
  • 15.5 RESEARCH ASSUMPTIONS
    • 15.5.1 STUDY ASSUMPTIONS
    • 15.5.2 GROWTH RATE ASSUMPTIONS
  • 15.6 RISK ASSESSMENT
  • 15.7 RESEARCH LIMITATIONS

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
    • 16.3.1 PRODUCT ANALYSIS
    • 16.3.2 GEOGRAPHIC ANALYSIS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 COLD PLASMA MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES
  • TABLE 3 WHITE SPACE OPPORTUNITIES IN COLD PLASMA MARKET
  • TABLE 4 INTERCONNECTED MARKETS IN COLD PLASMA MARKET
  • TABLE 5 CROSS-SECTOR OPPORTUNITIES IN COLD PLASMA MARKET
  • TABLE 6 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS IN COLD PLASMA MARKET
  • TABLE 7 COLD PLASMA MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 8 GDP CHANGE, BY KEY COUNTRY, 2021-2030 (IN USD BILLION)
  • TABLE 9 AVERAGE SELLING PRICE TREND OF COLD PLASMA PRODUCTS, BY KEY PLAYER, 2023-2025 (USD)
  • TABLE 10 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION (2023-2025) (USD)
  • TABLE 11 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2021-2025 (USD THOUSANDS)
  • TABLE 12 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2021-2025 (USD THOUSANDS)
  • TABLE 13 COLD PLASMA MARKET: MAJOR CONFERENCES & EVENTS IN 2026-2027
  • TABLE 14 US ADJUSTED RECIPROCAL TARIFF RATES,2025
  • TABLE 15 COLD PLASMA MARKET: MAJOR PATENTS
  • TABLE 16 KEY COMPANIES IMPLEMENTING AI IN COLD PLASMA MARKET
  • TABLE 17 BEST PRACTICES IN COLD PLASMA MARKET
  • TABLE 18 BEST PRACTICES IN CASE STUDIES OF AI IMPLEMENTATION IN THE COLD PLASMA MARKET
  • TABLE 19 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
  • TABLE 20 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY INDUSTRY
  • TABLE 25 KEY BUYING CRITERIA FOR COLD PLASMA, BY INDUSTRY
  • TABLE 26 ADOPTION BARRIERS AND INTERNAL CHALLENGES IN THE COLD PLASMA MARKET
  • TABLE 27 UNMET NEEDS IN COLD PLASMA MARKET FROM VARIOUS END USERS
  • TABLE 28 COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 29 COLD PLASMA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 30 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE POLYMER & PLASTIC INDUSTRY
  • TABLE 31 COLD PLASMA MARKET FOR THE POLYMER & PLASTIC INDUSTRY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 32 COMPARISON BETWEEN PLASMA TREATMENT AND TRADITIONAL TEXTILE PROCESSING
  • TABLE 33 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE TEXTILE INDUSTRY
  • TABLE 34 COLD PLASMA MARKET FOR THE TEXTILE INDUSTRY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 35 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE ELECTRONICS & SEMICONDUCTOR INDUSTRY
  • TABLE 36 COLD PLASMA MARKET FOR ELECTRONICS & SEMICONDUCTOR INDUSTRY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 37 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE FOOD & AGRICULTURE INDUSTRY
  • TABLE 38 COLD PLASMA MARKET FOR THE FOOD & AGRICULTURE INDUSTRY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 39 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE MEDICAL INDUSTRY
  • TABLE 40 COLD PLASMA MARKET FOR THE MEDICAL INDUSTRY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 41 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE COSMETICS INDUSTRY
  • TABLE 42 COLD PLASMA MARKET FOR THE COSMETICS INDUSTRY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 43 KEY PLAYERS PROVIDING PRODUCTS FOR THE PHARMACEUTICAL INDUSTRY
  • TABLE 44 COLD PLASMA MARKET FOR THE PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 45 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR OTHER INDUSTRIES
  • TABLE 46 COLD PLASMA MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 47 COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 48 COLD PLASMA MARKET FOR APPLICATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 49 COLD PLASMA MARKET FOR SURFACE TREATMENT & ACTIVATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 50 COLD PLASMA MARKET FOR COATING & THIN-FILM DEPOSITION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 COLD PLASMA MARKET FOR PRINTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 52 COLD PLASMA MARKET FOR STERILIZATION & DECONTAMINATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 53 COLD PLASMA MARKET FOR WOUND HEALING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 54 COLD PLASMA MARKET FOR SURFACE ETCHING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 55 COLD PLASMA MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 56 COLD PLASMA MARKET FOR AESTHETIC SKIN PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 57 COLD PLASMA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 58 COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 59 COLD PLASMA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 60 ATMOSPHERIC COLD PLASMA MARKET, BY REGION, BY VOLUME, 2024-2031 (MILLION UNITS)
  • TABLE 61 ATMOSPHERIC COLD PLASMA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 62 LOW PRESSURE COLD PLASMA MARKET, BY REGION, BY VOLUME, 2024-2031 (MILLION UNITS)
  • TABLE 63 LOW-PRESSURE COLD PLASMA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 64 COLD PLASMA MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 65 NORTH AMERICA: COLD PLASMA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 66 NORTH AMERICA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 67 NORTH AMERICA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (MILLION UNITS)
  • TABLE 68 NORTH AMERICA: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 69 NORTH AMERICA: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 70 US: MACROECONOMIC INDICATORS
  • TABLE 71 US: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 72 US: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 73 US: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 74 CANADA: MACROECONOMIC INDICATORS
  • TABLE 75 CANADA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 76 CANADA: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 77 CANADA: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 78 EUROPE: COLD PLASMA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 79 EUROPE: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 80 EUROPE: COLD PLASMA MARKET, BY REGIME, 2024-2031 (MILLION UNITS)
  • TABLE 81 EUROPE: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 82 EUROPE: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 83 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 84 GERMANY: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 85 GERMANY: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 86 GERMANY: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 87 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 88 FRANCE: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 89 FRANCE: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 90 FRANCE: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 91 UK: MACROECONOMIC INDICATORS
  • TABLE 92 UK: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 93 UK: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 94 UK: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 95 ITALY: MACROECONOMIC INDICATORS
  • TABLE 96 ITALY: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 97 ITALY: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 98 ITALY: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 99 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 100 SPAIN: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 101 SPAIN: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 102 SPAIN: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 103 REST OF EUROPE: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 104 REST OF EUROPE: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 105 REST OF EUROPE: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: COLD PLASMA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024-2031 (MILLION UNITS)
  • TABLE 109 ASIA PACIFIC: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 111 CHINA: MACROECONOMIC INDICATORS
  • TABLE 112 CHINA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 113 CHINA: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 114 CHINA: COLD PLASMA MARKET FOR THE TEXTILE INDUSTRY, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 115 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 116 JAPAN: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 117 JAPAN: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 118 JAPAN: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 119 INDIA: MACROECONOMIC INDICATORS
  • TABLE 120 INDIA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 121 INDIA: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 122 INDIA: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 123 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 124 AUSTRALIA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 125 AUSTRALIA: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 126 AUSTRALIA: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 127 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 128 SOUTH KOREA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 129 SOUTH KOREA: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 130 SOUTH KOREA: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 131 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 132 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 133 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 134 LATIN AMERICA: COLD PLASMA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 135 LATIN AMERICA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 136 LATIN AMERICA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (MILLION UNITS)
  • TABLE 137 LATIN AMERICA: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 138 LATIN AMERICA: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 139 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 140 BRAZIL: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 141 BRAZIL: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 142 BRAZIL: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 143 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 144 MEXICO: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 145 MEXICO: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 146 MEXICO: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 147 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 148 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 149 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 150 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 151 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 152 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (MILLION UNITS)
  • TABLE 153 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 154 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 155 GCC COUNTRIES: COLD PLASMA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 156 GCC COUNTRIES: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 157 GCC COUNTRIES: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 158 GCC COUNTRIES: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 159 KINGDOM OF SAUDI ARABIA: MACROECONOMIC INDICATORS
  • TABLE 160 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 161 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 162 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 163 UAE: MACROECONOMIC INDICATORS
  • TABLE 164 UAE: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 165 UAE: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 166 UAE: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 167 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 168 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 169 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 170 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME, 2024-2031 (USD MILLION)
  • TABLE 171 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY INDUSTRY, 2024-2031 (USD MILLION)
  • TABLE 172 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 173 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS, JANUARY 2023-JULY 2026
  • TABLE 174 COLD PLASMA MARKET: DEGREE OF COMPETITION
  • TABLE 175 US COLD PLASMA MARKET: DEGREE OF COMPETITION
  • TABLE 176 EUROPE COLD PLASMA MARKET: DEGREE OF COMPETITION
  • TABLE 177 COLD PLASMA MARKET: REGION FOOTPRINT
  • TABLE 178 COLD PLASMA MARKET: INDUSTRY FOOTPRINT
  • TABLE 179 COLD PLASMA MARKET: APPLICATION FOOTPRINT
  • TABLE 180 COLD PLASMA MARKET: REGIME FOOTPRINT
  • TABLE 181 COLD PLASMA MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 182 COLD PLASMA MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS
  • TABLE 183 COLD PLASMA MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 184 COLD PLASMA MARKET: DEALS, JANUARY 2023-JULY 2026
  • TABLE 185 COLD PLASMA MARKET: EXPANSIONS, JANUARY 2023-JULY 2026
  • TABLE 186 COLD PLASMA MARKET: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 187 NORDSON CORPORATION: COMPANY OVERVIEW
  • TABLE 188 NORDSON CORPORATION: PRODUCTS OFFERED
  • TABLE 189 NORDSON CORPORATION: DEALS, JANUARY 2023-JULY 2026
  • TABLE 190 NORDSON CORPORATION: EXPANSIONS, JANUARY 2023-JULY 2026
  • TABLE 191 NORDSON CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 192 ADTEC PLASMA TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 193 ADTEC PLASMA TECHNOLOGY CO., LTD: PRODUCTS OFFERED
  • TABLE 194 ADTEC PLASMA TECHNOLOGY CO., LTD.: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
  • TABLE 195 ADTEC PLASMA TECHNOLOGY CO., LTD.: DEALS, JANUARY 2023-JULY 2026
  • TABLE 196 ADTEC PLASMA TECHNOLOGY CO., LTD.: EXPANSIONS, JANUARY 2023-JULY 2026
  • TABLE 197 ADTEC PLASMA TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 198 JUDGES SCIENTIFIC PLC: COMPANY OVERVIEW
  • TABLE 199 JUDGES SCIENTIFIC PLC: PRODUCTS OFFERED
  • TABLE 200 JUDGES SCIENTIFIC PLC: PRODUCT LAUNCHES & UPDATES, JANUARY 2023-JULY 2026
  • TABLE 201 JUDGES SCIENTIFIC PLC: DEALS, JANUARY 2023- JULY 2026
  • TABLE 202 PVA TEPLA AG: COMPANY OVERVIEW
  • TABLE 203 PVA TEPLA AG: PRODUCTS OFFERED
  • TABLE 204 BODYCOTE.: COMPANY OVERVIEW
  • TABLE 205 BODYCOTE: PRODUCTS OFFERED
  • TABLE 206 BODYCOTE: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 207 APYX MEDICAL CORPORATION: COMPANY OVERVIEW
  • TABLE 208 APYX MEDICAL CORPORATION: PRODUCTS OFFERED
  • TABLE 209 APYX MEDICAL CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 210 APYX MEDICAL CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 211 VIROMED MEDICAL AG: COMPANY OVERVIEW
  • TABLE 212 VIROMED MEDICAL AG: PRODUCTS OFFERED
  • TABLE 213 VIROMED MEDICAL AG: PRODUCT APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 214 VIROMED MEDICAL AG: DEALS, JANUARY 2023- JULY 2026
  • TABLE 215 VIROMED MEDICAL AG: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 216 SAMCO INC.: COMPANY OVERVIEW
  • TABLE 217 SAMCO INC.: PRODUCTS OFFERED
  • TABLE 218 SAMCO INC.: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
  • TABLE 219 MYCRONIC: COMPANY OVERVIEW
  • TABLE 220 MYCRONIC: PRODUCTS OFFERED
  • TABLE 221 MYCRONIC: DEALS, JANUARY 2023- JULY 2026
  • TABLE 222 MYCRONIC: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 223 PLASMATREAT GMBH: COMPANY OVERVIEW
  • TABLE 224 PLASMATREAT GMBH: PRODUCTS OFFERED
  • TABLE 225 PLASMATREAT GMBH: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
  • TABLE 226 PLASMATREAT GMBH: DEALS, JANUARY 2023- JULY 2026
  • TABLE 227 PLASMATREAT GMBH: EXPANSIONS, JANUARY 2023-JULY 2026
  • TABLE 228 PLASMATREAT GMBH: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 229 P2I LTD: COMPANY OVERVIEW
  • TABLE 230 P2I LTD: PRODUCTS OFFERED
  • TABLE 231 P2I LTD: DEALS, JANUARY 2023- JULY 2026
  • TABLE 232 P2I LTD: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 233 ENERCON INDUSTRIES CORPORATION: COMPANY OVERVIEW
  • TABLE 234 ENERCON INDUSTRIES CORPORATION: PRODUCTS OFFERED
  • TABLE 235 ENERCON INDUSTRIES CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
  • TABLE 236 ENERCON INDUSTRIES CORPORATION: EXPANSIONS, JANUARY 2023-JULY 2026
  • TABLE 237 TANTEC A/S: COMPANY OVERVIEW
  • TABLE 238 TANTEC A/S: PRODUCTS OFFERED
  • TABLE 239 TANTEC A/S: SERVICE LAUNCHES, JANUARY 2023- JULY 2026
  • TABLE 240 TANTEC A/S: DEALS, JANUARY 2023- JULY 2026
  • TABLE 241 ACXYS TECHNOLOGIES.: COMPANY OVERVIEW
  • TABLE 242 ACXYS TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 243 ACXYS TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2023- JULY 2026
  • TABLE 244 KEYLINK: COMPANY OVERVIEW
  • TABLE 245 KEYLINK: PRODUCTS OFFERED
  • TABLE 246 KEYLINK: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 247 STUDY ASSUMPTIONS
  • TABLE 248 COLD PLASMA MARKET: RISK ASSESSMENT ANALYSIS

List of Figures

  • FIGURE 1 MARKET SCENARIO
  • FIGURE 2 GLOBAL COLD PLASMA MARKET, 2024-2031
  • FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS COLD PLASMA MARKET, 2024-2026
  • FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF COLD PLASMA MARKET
  • FIGURE 5 HIGH-GROWTH SEGMENTS IN COLD PLASMA MARKET, 2026-2031
  • FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN COLD PLASMA MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
  • FIGURE 7 INCREASING USE OF COLD PLASMA FOR STERILIZATION, SURFACE TREATMENT, AND DECONTAMINATION TO DRIVE MARKET GROWTH
  • FIGURE 8 POLYMER & PLASTICS INDUSTRY ACCOUNTED FOR LARGEST SHARE IN 2025
  • FIGURE 9 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 10 COLD PLASMA MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 11 COLD PLASMA MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 12 SUPPLY CHAIN ANALYSIS
  • FIGURE 13 COLD PLASMA PRODUCT AND SERVICE MANUFACTURING & RESEARCH MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 14 COLD PLASMA MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 15 AVERAGE SELLING PRICE TREND OF COLD PLASMA PRODUCTS, BY REGIME, 2023-2025 (USD)
  • FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES IN COLD PLASMA MARKET
  • FIGURE 17 INVESTMENT & FUNDING SCENARIO (2023-2026)
  • FIGURE 18 COLD PLASMA MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2016-JULY 2026)
  • FIGURE 19 TOP APPLICANT COUNTRIES/REGIONS FOR COLD PLASMA GENERATORS (JANUARY 2016-JULY 2026)
  • FIGURE 20 KEY FEATURES OF AI/GENERATIVE AI IN COLD PLASMA MARKET
  • FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY INDUSTRY
  • FIGURE 22 KEY BUYING CRITERIA FOR COLD PLASMA, BY INDUSTRY
  • FIGURE 23 NORTH AMERICA: COLD PLASMA MARKET SNAPSHOT (2025)
  • FIGURE 24 ASIA PACIFIC: COLD PLASMA MARKET SNAPSHOT (2025)
  • FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN COLD PLASMA MARKET, 2023-2025
  • FIGURE 26 GLOBAL MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
  • FIGURE 27 US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
  • FIGURE 28 EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
  • FIGURE 29 COLD PLASMA MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 30 COLD PLASMA MARKET: COMPANY FOOTPRINT
  • FIGURE 31 COLD PLASMA MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 32 EV/EBITDA OF KEY VENDORS FOR COLD PLASMA MARKET
  • FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS FOR COLD PLASMA MARKET
  • FIGURE 34 COLD PLASMA MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 35 NORDSON CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 36 ADTEC PLASMA TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT (2025)
  • FIGURE 37 JUDGES SCIENTIFIC PLC: COMPANY SNAPSHOT (2025)
  • FIGURE 38 PVA TEPLA AG: COMPANY SNAPSHOT (2025)
  • FIGURE 39 BODYCOTE: COMPANY SNAPSHOT (2025)
  • FIGURE 40 APYX MEDICAL CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 41 VIROMED MEDICAL AG: COMPANY SNAPSHOT (2025)
  • FIGURE 42 SAMCO INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 43 MYCRONIC: COMPANY SNAPSHOT (2025)
  • FIGURE 44 COLD PLASMA MARKET: RESEARCH DESIGN
  • FIGURE 45 PRIMARY SOURCES
  • FIGURE 46 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
  • FIGURE 49 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 50 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 51 REVENUE SHARE ANALYSIS ILLUSTRATION: NORDSON CORPORATION (2025)
  • FIGURE 52 BOTTOM-UP APPROACH
  • FIGURE 53 TOP-DOWN APPROACH
  • FIGURE 54 SUPPLY-SIDE ANALYSIS: COLD PLASMA MARKET (2025)
  • FIGURE 55 DEMAND-SIDE APPROACH
  • FIGURE 56 COLD PLASMA MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026-2031)
  • FIGURE 57 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
  • FIGURE 58 MARKET DATA TRIANGULATION METHODOLOGY